期刊文献+

阿立哌唑治疗女性阴性症状精神分裂症疗效研究

Treatment Efficacy of Women with Negative Symptoms of Schizophrenia with Aripiprazole
下载PDF
导出
摘要 目的:研究阿立哌唑治疗女性阴性症状为主精神分裂症的疗效和安全性。方法:对符合CCMD-3精神分裂症诊断标准、阴性症状评定量表(SANS)≥50分、临床总体印象量表(CGI)≥4的60例女性分裂症患者。随机分为阿立哌唑治疗组和利培酮治疗组,疗程为8周。阿立哌唑组30例,口服阿立哌唑(20.52±5.28)mg/d;利培酮组(5.31±1.47)mg/d。用阴性症状量表(SANS)、临床总体印象量表(CGI)评定疗效,用药物副反应量表(TESS)评定不良反应。结果:经SANS、CGI评定,两组治疗后2周、4周、8周均与治疗前比较具有显著性差别(P<0.01)。临床总体疗效在统计学上无显著性差别(P>0.05),TESS量表评定,阿立哌唑组锥体外系反应少、无体重增加、月经紊乱及泌乳。利培酮组震颤、锥体外系反应、体重增加、月经紊乱、溢乳等反应发生率高。阿立哌唑副反应明显少于利培酮。结论:阿立哌唑治疗女性精神分裂症阴性症状临床疗效良好,且副作用小,安全性高。 Objective: To evaluate the efficacy and the safety of Aripiprazole and Risperidone for treatment of women with schizophrenia negative symptoms. Methods: Of 60 women with schizophrenia, who were eligible because CCMD-3 and SANS score≥50, and CGI score≥4, 30 were assigned to the aripiprazole group (20.52 ± 5.28mg/d for 8 weeks, oral) and 30 to the risperidone group(5.31 ± 1.47mg/d for 8 weeks, oral). All participants were assessed by SANS , CGI and TESS before and after 2,4 and 8 weeks treatment. Results:There were signifieanfly difference on SANS and CGI between before and after treatment (P 〈 0.01 ). The total clinical efficacy showed not statistically significant difference between two groups (P 〉 0.05 ). Aripiprazole got a good response in all target symptoms of SANS and CGI and had fewer side effects than Risperidone. Conclusions:Aripiprazole has an effective treatment for women with schizophrenia negative symptoms and has fewer side effects.
出处 《青海医药杂志》 2009年第7期8-10,共3页 Qinghai Medical Journal
关键词 阿立哌唑 利培酮 精神分裂症 阴性症状 女性 Aripiprazole Risperidone Schizophrenia Negative symptoms Women
  • 相关文献

参考文献3

  • 1韦有芳,王晓枫.阿立哌唑治疗精神分裂症的疗效对照研究[J].四川精神卫生,2006,19(3):173-174. 被引量:7
  • 2中华医学会精神科分会.中国精神障碍分类与诊断标准.第3版(CCMD-3).济南:山东科技出版社,2001,75-78.
  • 3张明圆.精神科评定量表手册.第2版.长沙:湖南科学出版社,2003,94-202.

二级参考文献2

  • 1Jordan S,Koprivica V,Chen R,et al.The antipsychotic aripiprazole is a potent,partial agonist at the human 5-HT1A receptor.Eur J Pharmacol,2002,41 (1):137 ~ 140.
  • 2中华医学会精神科分会.中国精神障碍分类与诊断标准(CCMD -3).济南:山东科学技术出版社.2004.75~77.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部